Insights

Innovation & Recognition Cellomatics Biosciences has received multiple awards for innovation and international trade, including the Queen's Award and the Barclays Entrepreneur Award, highlighting its reputation for cutting-edge solutions and expanding global influence, which can be leveraged to attract clients seeking advanced preclinical services.

New Platform Launches The company recently launched proprietary models such as INNOBEX and new platforms in NASH and pulmonary fibrosis, indicating a continuous pipeline of innovative tools that can meet diverse and emerging research needs in biotech and pharma industries.

Strategic Expansion Recognition through awards and recent hires, including a new Chief Scientific Officer, demonstrate Cellomatics' focus on growth and enhanced scientific capabilities, presenting opportunities to collaborate on sophisticated drug discovery projects.

Market Focus & Expertise Specialized in immunology and human cell-based models, Cellomatics provides high-quality, customizable assays supporting drug development, biomarker validation, and translational research, making it a strategic partner for companies seeking reliable preclinical testing.

Growth & Outreach Active participation in global awards and industry events, coupled with a solid revenue base between $1M and $10M, signals a company open to partnerships, licensing, and expanding service offerings, creating sales opportunities in international markets.

Cellomatics BioSciences Ltd Tech Stack

Cellomatics BioSciences Ltd uses 8 technology products and services including RSS, Microsoft Excel, Google Fonts API, and more. Explore Cellomatics BioSciences Ltd's tech stack below.

  • RSS
    Content Management System
  • Microsoft Excel
    Editors
  • Google Fonts API
    Font Scripts
  • Microsoft
    Miscellaneous
  • LinkedIn
    Online Community Software
  • Priority Hints
    Performance
  • X-XSS-Protection
    Security
  • Google Tag Manager
    Tag Management

Media & News

Cellomatics BioSciences Ltd's Email Address Formats

Cellomatics BioSciences Ltd uses at least 1 format(s):
Cellomatics BioSciences Ltd Email FormatsExamplePercentage
F.Last@cellomaticsbio.comJ.Doe@cellomaticsbio.com
48%
First.Last@cellomaticsbio.comJohn.Doe@cellomaticsbio.com
2%
F.Last@cellomaticsbio.comJ.Doe@cellomaticsbio.com
48%
First.Last@cellomaticsbio.comJohn.Doe@cellomaticsbio.com
2%

Frequently Asked Questions

What is Cellomatics BioSciences Ltd's official website and social media links?

Minus sign iconPlus sign icon
Cellomatics BioSciences Ltd's official website is cellomaticsbio.com and has social profiles on LinkedIn.

What is Cellomatics BioSciences Ltd's SIC code NAICS code?

Minus sign iconPlus sign icon
Cellomatics BioSciences Ltd's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cellomatics BioSciences Ltd have currently?

Minus sign iconPlus sign icon
As of December 2025, Cellomatics BioSciences Ltd has approximately 19 employees across 1 continents, including Europe. Key team members include Founder - Ceo: S. S.Study And Operations Director: A. T.Consultant Finance Director: S. G.. Explore Cellomatics BioSciences Ltd's employee directory with LeadIQ.

What industry does Cellomatics BioSciences Ltd belong to?

Minus sign iconPlus sign icon
Cellomatics BioSciences Ltd operates in the Biotechnology Research industry.

What technology does Cellomatics BioSciences Ltd use?

Minus sign iconPlus sign icon
Cellomatics BioSciences Ltd's tech stack includes RSSMicrosoft ExcelGoogle Fonts APIMicrosoftLinkedInPriority HintsX-XSS-ProtectionGoogle Tag Manager.

What is Cellomatics BioSciences Ltd's email format?

Minus sign iconPlus sign icon
Cellomatics BioSciences Ltd's email format typically follows the pattern of F.Last@cellomaticsbio.com. Find more Cellomatics BioSciences Ltd email formats with LeadIQ.

When was Cellomatics BioSciences Ltd founded?

Minus sign iconPlus sign icon
Cellomatics BioSciences Ltd was founded in 2015.

Cellomatics BioSciences Ltd

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Cellomatics is an ISO-certified, specialised preclinical CRO with expertise in translational human cell-based models. We support drug discovery across multiple therapeutic areas by capturing disease biology in physiologically relevant systems, enabling more predictive and clinically meaningful insights.

At Cellomatics Biosciences Ltd., we understand the complexities of immunology research and the importance of generating data you can trust. Our immunology assay services are designed to accelerate discovery and development through high-quality, customizable solutions that address the unique needs of every project.

We combine:
•	Scientific expertise to ensure robust study design and execution
•	Fresh donor material sourced through our in-house volunteer recruitment and recall system
•	Advanced technologies including flow cytometry, multiplex cytokine analysis, and high-content imaging
This powerful integration enables us to deliver reliable, reproducible results that provide actionable insights into immune function and response.

Whether you are:
•	Developing novel therapeutics
•	Validating biomarkers
•	Advancing translational research
…our experienced team provides the infrastructure, flexibility, and collaboration needed to support your goals from concept through to completion.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Cellomatics BioSciences Ltd's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Cellomatics BioSciences Ltd's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.